The Amanta Healthcare IPO closes today, September 3, 2025, after opening for subscription on September 1, 2025. The ₹126 crore IPO has seen significant investor interest, with the issue being oversubscribed.
Subscription Status
As of today, September 3, 2025, around 11:15 AM IST, the IPO has been subscribed over 32 times. By the end of the second day, September 2, 2025, the IPO was subscribed 19.63 times. The breakdown of subscription by investor category as of September 3, 2025 10:09:33 AM is as follows:
Non-institutional investors (NIIs) have oversubscribed their portion by 69.14 times. On Day 2, the NII portion was subscribed 36.41 times, and the retail portion was subscribed 23.35 times. Qualified Institutional Buyers (QIBs) showed a more cautious approach, with their portion subscribed only 0.53 times on day 2.
Grey Market Premium (GMP)
The Grey Market Premium (GMP) for Amanta Healthcare IPO has fluctuated. On September 1st, the GMP reached a high of ₹29, later decreasing to ₹13 by September 3rd. As of September 2, 2025, the GMP was around ₹12, suggesting a potential listing price of ₹138 per share, based on the upper price band of ₹126. This indicates a potential gain of 9.52% per share. Some reports suggest the GMP is at ₹29, indicating a 22% premium over the IPO price.
It's important to note that GMP is an unofficial indicator and is subject to market volatility.
IPO Details
Objectives of the Issue
The funds raised from the IPO will be used for:
Financial Performance
For the fiscal year 2025, Amanta Healthcare reported a revenue of ₹276.09 crore, slightly lower than ₹281.61 crore in FY24. However, profit after tax (PAT) saw a significant increase of 189% to ₹10.5 crore in FY25, compared to ₹3.63 crore in the previous year.
Anchor Investors
Prior to the IPO, Amanta Healthcare secured ₹37.8 crore from six anchor investors, allotting them 3 million equity shares at ₹126 per share.
How to Check Allotment Status
The allotment status can be checked on the websites of BSE and NSE.
On BSE:
On NSE:
